Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives — Monica Margoni (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Shared by
Massimo Filippi
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives
Article
2021
en
Authors
+1 more
MM
Monica Margoni
PP
Paolo Preziosa
Massimo Filippi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2008
MRI in multiple sclerosis: current status and future prospects
Rohit Bakshi
,
Alan J. Thompson
,
Maria A. Rocca
,
Daniel Pelletier
,
Vincent Dousset
,
Frederik Barkhof
,
Matilde Inglese
,
Charles R.G. Guttmann
,
Mark A. Horsfield
,
Massimo Filippi
Article
2018
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives
Maria A. Rocca
,
Paolo Preziosa
,
Massimo Filippi
Editorial Material
2016
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Masatoshi Kudo
Article
2024
[Current status and future perspectives of interventional endoscopic ultrasound-guided treatment].
Mamoru Takenaka
,
Masatoshi Kudo
Article
2020
Current perspectives on co-morbid depression and multiple sclerosis
Scott Burton Patten
Discussion(0)
No comments yet. Be the first to comment.